Marcelle Machluf
Oprichter bij NanoGhost Ltd.
Actieve functies van Marcelle Machluf
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Technion-Israel Institute of Technology | Corporate Officer/Principal | - | - |
NanoGhost Ltd.
 NanoGhost Ltd. Packaged SoftwareTechnology Services NanoGhost Ltd. is an Israeli biotech company that specializes in developing a drug delivery platform called Nano-Ghosts/NGs. The company is based in Netanya, Israel. The platform is highly selective and is derived from the cell membrane of mesenchymal stem cells (MSCs), which have a known affinity for cancer and sites of inflammation. The company was founded in 2019 by Marcelle Machluf. Yonatan Malca has been the CEO of the company since 2019. | Directeur/Bestuurslid | 14-08-2019 | - |
| Oprichter | 14-08-2019 | - |
Loopbaan van Marcelle Machluf
Eerdere bekende functies van Marcelle Machluf
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ERECH FINANCE CAHALACHA LTD | Directeur/Bestuurslid | 27-10-2010 | 27-10-2019 |
| Independent Dir/Board Member | 27-10-2010 | 27-10-2019 |
Opleiding van Marcelle Machluf
| Ben-Gurion University of the Negev | Doctorate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Statistieken
Internationaal
| Israël | 6 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ERECH FINANCE CAHALACHA LTD | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NanoGhost Ltd.
NanoGhost Ltd. Packaged SoftwareTechnology Services NanoGhost Ltd. is an Israeli biotech company that specializes in developing a drug delivery platform called Nano-Ghosts/NGs. The company is based in Netanya, Israel. The platform is highly selective and is derived from the cell membrane of mesenchymal stem cells (MSCs), which have a known affinity for cancer and sites of inflammation. The company was founded in 2019 by Marcelle Machluf. Yonatan Malca has been the CEO of the company since 2019. | Technology Services |
- Beurs
- Insiders
- Marcelle Machluf
- Ervaring
